dr. K. (Kathelijn) Fischer

dr. K. (Kathelijn) Fischer

Associate Professor - medical
dr. K. (Kathelijn) Fischer
  • Hematology/Van Creveldclinic

Research Programs



Kathelijn Fischer has been working at the University Medical Center Utrecht, both as a Paediatric Haematologist and a Clinical Epidemiologist.

Dr Fischer finished her medical training in 1988 is a registered paediatrician since 1994. Dr Fischer specialized in paediatric haematology and oncology in Utrecht, the Netherlands. Subsequently, she performed PhD research in haemophilia while training as a clinical epidemiologist. She published her thesis on ‘Treatment strategies in severe haemophilia: in search for the optimal treatment’ in 2001.

Dr Fischer supervises four PhD students and served as co-promotor for seven other PhD students in the field of haematology, neurology and gynaecology.

Dr Fischer is principal investigator in several international studies on long-term results of haemophilia treatment, and is the epidemiologist for the European Haemophilia Safety Surveillance Study (EUHASS-member of the steering committee) as well as for the European PedNet registry.

The specific areas of expertise and interest of dr Fischer include the epidemiology of haemophilia (including use of registries), prophylactic treatment, and outcome assessment in haemophilia care.

Side Activities

  • Membership of international working groups: International Prophylaxis Study Group (IPSG), European Association for Haemophilia and Allied Disorders (EAHAD; former EC member), she is a former co-chair of the FVIII/IX SSC subcommittee of the ISTH and participated in the group that drafted the Principles of Haemophilia Care.
  • Member of the National Haemophilia Registry Committee of the Dutch Haemophilia Treaters Board (NVHB)
  • Membership professional organisations: NVK (Dutch Paediatric Society,- section benign haematology), ISTH (International Society for Thrombosis and Haemostasis), WFH (World Federation for Haemophilia)
  • Section editor for Thrombosis and Haemostasis journal, member of the editorial board for Haemophilia journal

Fellowship and Awards

Bayer Haemophilia Special Project Award (2005)

Research Output (294)

Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: data from the WAPPS database

Versloot Olav, Iserman Emma, Chelle Pierre, Germini Federico, Edginton Andrea N, Schutgens Roger E, Iorio Alfonso, Fischer Kathelijn aug 2021, In: Journal of Thrombosis and Haemostasis. 19 , p. 1896-1906

Final results of the PUPs B-LONG study:Evaluating safety and efficacy of rFIXFc in previously untreated patients with hemophilia B

Nolan Beatrice, Klukowska Anna, Shapiro Amy, Rauch Antoine, Recht Michael, Ragni Margaret, Curtin Julie, Gunawardena Sriya, Mukhopadhyay Sutirtha, Jayawardene Deepthi, Winding Bent, Fischer Kathelijn, Liesner Raina 13 jul 2021, In: Blood Advances. 5 , p. 2732-2739 8 p.

Adherence to prophylaxis and its association with activation of self-management and treatment satisfaction

Hoefnagels Johanna Wilhelmina, Schrijvers Liesbeth Hélène, Leebeek Frank W.G., Eikenboom Jeroen, Schols Saskia E.M., Smit Cees, Schutgens Roger E.G., Gouw Samantha C., Fischer Kathelijn, jul 2021, In: Haemophilia. 27 , p. 581-590 10 p.

A tailored intervention for illness acceptance improves adherence and quality of life in adults with haemophilia using prophylaxis

Hoefnagels Johanna Wilhelmina , Fischer Kathelijn, Bos Ruud A.T., Driessens Mariette H.E., Schrijvers Liesbeth H. jul 2021, In: Haemophilia. 27 , p. e434-e440

Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial):an open-label, multicentre, randomised, controlled trial

van Moort Iris, Preijers Tim, Bukkems Laura H., Hazendonk Hendrika C.A.M., van der Bom Johanna G., Laros-van Gorkom Britta A.P., Beckers Erik E.A.M., Nieuwenhuizen Laurens, van der Meer Felix J.M., Ypma Paula, Coppens Michiel, Fijnvandraat Karin, Schutgens Roger E.G., Meijer Karina, Leebeek Frank W.G., Mathôt Ron A.A., Cnossen Marjon H., Schutgens Roger E.G., Fischer Kathelijne, Van Galen Karin P.M., jul 2021, In: The Lancet Haematology. 8 , p. e492-e502

Similar sports participation as the general population in Dutch persons with haemophilia; results from a nationwide study

Versloot Olav, van Balen Erna C, Hassan Shermarke, Schols Saskia E M, Leebeek Frank W G, Eikenboom Jeroen, Coppens Michiel, van Vulpen Lize F D, Smit Cees, Driessens Mariëtte H E, van der Net Janjaap, Gouw Samantha C, Fischer Kathelijn, 19 jun 2021, In: Haemophilia. 27 , p. 876-885 10 p.

Alternatives for Vitamin K Antagonists as Thromboprophylaxis for Mechanical Heart Valves and Mechanical Circulatory Support Devices:A Systematic Review

Liesdek Omayra C D, Urbanus Rolf T, de Heer Linda M, Fischer Kathelijn, Suyker Willem J L, Schutgens Roger E G 31 mei 2021, In: Seminars in Thrombosis and Hemostasis. 47 , p. 724-734 11 p.

Role of Regulatory Cells in Immune Tolerance Induction in Hemophilia A

Schep Sarah, Schutgens Roger E, Fischer Kathelijn, Voorberg Jan, Boes Marianne mei 2021, In: Hemasphere. 5 9 p.

PROTECT VIII kids extension study:Long-term safety and efficacy of BAY 94-9027 (damoctocog alfa pegol) in children with severe haemophilia A

Mancuso Maria Elisa, Biss Tina, Fischer Kathelijn, Maas Enriquez Monika, Steele MacGregor, Wang Maria, Tseneklidou-Stoeter Despina, Ahuja Sanjay, Kenet Gili mei 2021, In: Haemophilia. 27 , p. 434-444 11 p.

Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B:A PedNet study

Male Christoph, Andersson Nadine G., Rafowicz Anne, Liesner Ri, Kurnik Karin, Fischer Kathelijn, Platokouki Helen, Santagostino Elena, Chambost Hervé, Nolan Beatrice, Königs Christoph, Kenet Gili, Ljung Rolf, Van Den Berg H. Marijke, jan 2021, In: Haematologica. 106 , p. 123-129 7 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet